NDC 17139-400

Binosto

Alendronate Sodium

Binosto is a Oral Tablet, Effervescent in the Human Prescription Drug category. It is labeled and distributed by Ascend Therapeutics. The primary component is Alendronate Sodium.

Product ID17139-400_179a5f2b-a181-4511-a23a-2f349dd66a7b
NDC17139-400
Product TypeHuman Prescription Drug
Proprietary NameBinosto
Generic NameAlendronate Sodium
Dosage FormTablet, Effervescent
Route of AdministrationORAL
Marketing Start Date2012-09-03
Marketing CategoryNDA / NDA
Application NumberNDA202344
Labeler NameASCEND Therapeutics
Substance NameALENDRONATE SODIUM
Active Ingredient Strength70 mg/1
Pharm ClassesBisphosphonate [EPC],Diphosphonates [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 17139-400-01

1 TABLET, EFFERVESCENT in 1 CARTON (17139-400-01)
Marketing Start Date2019-11-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17139-400-00 [17139040000]

Binosto TABLET, EFFERVESCENT
Marketing CategoryNDA
Application NumberNDA202344
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-11-27
Marketing End Date2019-12-10

NDC 17139-400-04 [17139040004]

Binosto TABLET, EFFERVESCENT
Marketing CategoryNDA
Application NumberNDA202344
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-11-27

NDC 17139-400-01 [17139040001]

Binosto TABLET, EFFERVESCENT
Marketing CategoryNDA
Application NumberNDA202344
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
ALENDRONATE SODIUM70 mg/1

Pharmacological Class

  • Bisphosphonate [EPC]
  • Diphosphonates [CS]

NDC Crossover Matching brand name "Binosto" or generic name "Alendronate Sodium"

NDCBrand NameGeneric Name
0178-0101Binostoalendronate sodium
17139-400Binostoalendronate sodium
10135-696AlendronateAlendronate Sodium
10135-697AlendronateAlendronate Sodium
0054-0282Alendronate SodiumAlendronate Sodium
0115-1676Alendronate SodiumAlendronate Sodium
0115-1678Alendronate SodiumAlendronate Sodium
0115-1679Alendronate SodiumAlendronate Sodium
0115-1680Alendronate SodiumAlendronate Sodium
0115-1681Alendronate SodiumAlendronate Sodium
0378-3566Alendronate Sodiumalendronate sodium
16252-599alendronate sodiumalendronate sodium
16252-601alendronate sodiumalendronate sodium
16714-631Alendronate SodiumAlendronate Sodium
16714-632Alendronate SodiumAlendronate Sodium
16714-633Alendronate SodiumAlendronate Sodium
21695-901Alendronate Sodiumalendronate sodium
21695-902Alendronate Sodiumalendronate sodium
33261-554Alendronate SodiumAlendronate Sodium
33261-820Alendronate SodiumAlendronate Sodium
0006-0031FOSAMAXalendronate sodium

Trademark Results [Binosto]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BINOSTO
BINOSTO
85173657 4242545 Live/Registered
EFFRX PHARMACEUTICALS S.A.
2010-11-10
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.